Study Objectives: To examine the relationship between the delta lactate (3-hour lactate minus initial lactate) and in-hospital death.
Methods: This was an observational cohort study of consecutive patients diagnosed with sepsis in the emergency department who were coded as severe sepsis or septic shock during their hospital stay. Initial lactic acid, 3-hour lactic acid, and in-hospital mortality were abstracted onto pre-designed data collection sheets by abstractors blinded to outcome. A multivariate regression model was then performed to decipher predictors of in hospital mortality. The cohort included adults over the age of 18, ED diagnosis of severe sepsis, or septic shock by 2 or more of the following, temperature of more than 38 C (100.4 F) or less than 36 C (96.8 F), pulse rate of more than 90 beats per minute, respiratory rate of more than 20 breaths per minute, or abnormal white blood cell count (>12,000/mL or < 4,000/mL or >10% immature [band] forms) and associated with organ dysfunction, hypoperfusion, or hypotension (systolic blood pressure of less than 90 mmHg or a rapid decrease from baseline) or persistent hypotension and perfusion abnormalities despite adequate fluid resuscitation. Patients who developed sepsis after the ED visit (during hospitalization), patients transferred from another facility, or were less than 18 years of age were excluded.
Results: The cohort consisted of 163 patients who had an initial lactate drawn, 130 of which also got a 3-hour lactate. The median initial lactate was 2.64 with an interquartile range (IQR) of 1.71 to 4.62, and a range of 0.49 to 18.04. The median repeat lactate was 2.58, with an IQR of 1.4 to 3.9, and a range of 0.4 to 28.7. 25% of the cohort died during their hospital stay. For men, the in-hospital death rate was 23%, and for women, 29%. The delta lactate was significantly higher in women (p¼0.0070), driven by a lower initial lactate (P¼0.0277). Multivariate regression model controlled for age and sex demonstrated a statistically significant correlation between an increase in the delta lactate and in hospital death (p¼0.0323, R2¼11.3%).
Conclusions: An increase in the 3-hour lactic acid as compared to the initial lactic acid was significantly associated with higher in hospital death in our cohort. This information may be utilized to accelerate a higher level of care for these patients.
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Evaluating the Clinical Respiratory Score for Initiating High Flow Nasal Cannula in the Pediatric Emergency Department Cheng A, Simon H, Travers C, Hebbar KB/Emory University, Atlanta, GA Study Objectives: There are no established guidelines for the initiation of oxygen therapy in pediatric patients. With the increased utilization of high flow nasal cannula (HFNC) for patients with respiratory failure, it is critical to develop a systematic approach for the initiation of this oxygen delivery modality. Currently at our institution, providers utilize the Clinical Respiratory Score (CRS) to assess all respiratory distress patients in the emergency department (ED). CRS is a 12-point assessment that includes respiratory rate, work of breathing, wheezing, hypoxia, dyspnea, and cough. While this score serves as a guidance for asthma treatment, it is not extended to HFNC therapy decisionmaking. We investigate the correlation between CRS and HFNC use in the ED.
Methods: To determine the relationship between ED-assessed CRS and respiratory therapy, we completed a structured explicit retrospective chart review at a single institution between 2/1/15-12/13/16. We included all patients, 0-18 years old, admitted to the floor or Pediatric Intensive Care Unit (PICU) from the ED with an ED-assessed CRS. If a patient has multiple CRS during their course in the ED, only the first CRS was used in the analysis. Diagnosis code were used to include patients with asthma, pneumonia, bronchiolitis, viral upper respiratory illness, wheezing, and hypoxia. Patients who have tracheostomy tube, baseline oxygen dependence, cystic fibrosis, and croup were excluded from the study. We calculated the predicative values, sensitivity, and specificity for the CRS relative to the incidence of HFNC initiation in the ED. Additional stratification by diagnosis was conducted to understand patterns of assessment between patients with bronchiolitis, pneumonia, and asthma.
Results: A total of 1,093 patients were included in the assessment. The median age was 3.1 years (median 0.9, IQR 7.2). 63% of the cohort had a diagnosis of asthma; 35% of the cohort had a diagnosis of bronchiolitis; and 29.6% of the cohort had a diagnosis of pneumonia. With respect to ED-based supplemental oxygen treatment, 23% of the cohort received HFNC compared to 51% for NC. Patients receiving HFNC received a statistically significantly higher CRS compared to non-HFNC (HFNC mean 4.57, SD 1.87 versus non-HFNC mean 3.28, SD 1.98; p<0.001). Differences in distributions are slightly more pronounced for the bronchiolitis cohort (HFNC mean 4.26, SD ¼ 1.77 versus non-HFNC mean 2.65, SD 1.76; p<0.001) compared to asthma (HFNC mean 5.05, SD ¼ 1.73 versus non-HFNC mean 3.71, SD 1.92; p<0.001) and pneumonia (HFNC mean 4.63, SD ¼ 2.17 versus non-HFNC mean 3.05, SD 2.07; p<0.001). Stratification by diagnosis showed a CRS of 5 in the asthma cohort has sensitivity of 65% and specificity of 67%, and CRS of 4 in the bronchiolitis cohort has sensitivity of 71% and specificity of 71%.
Research Forum Abstracts

S88 Annals of Emergency Medicine
Volume 72, no. 4s : October 2018
